- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT02997228
Комбинация химиотерапии, бевацизумаба и/или атезолизумаба при лечении пациентов с метастатическим колоректальным раком с недостаточной репарацией несоответствия ДНК, исследование COMMIT
Метастатический колоректальный рак Исследование иммунотерапии dMMR/MSI-H (COMMIT): рандомизированное исследование фазы III комбинации mFOLFOX6/бевацизумаб/атезолизумаб по сравнению с монотерапией атезолизумабом в терапии первой линии пациентов с недостаточной репарацией несоответствия ДНК (dMMR)/микросателлитом Метастатический колоректальный рак с высокой нестабильностью (MSI-H)
This phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as fluorouracil, oxaliplatin, and leucovorin calcium, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of the tumor. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving combination chemotherapy, bevacizumab, and atezolizumab may work better in treating patients with colorectal cancer.
Обзор исследования
Статус
Вмешательство/лечение
- Другой: Quality-of-Life Assessment
- Биологический: Bevacizumab
- Лекарство: Fluorouracil
- Процедура: Magnetic Resonance Imaging
- Другой: Questionnaire Administration
- Процедура: Biospecimen Collection
- Лекарство: Atezolizumab
- Лекарство: Oxaliplatin
- Процедура: Computed Tomography
- Лекарство: Leucovorin
- Процедура: Positron Emission Tomography
Подробное описание
PRIMARY OBJECTIVE:
I. To determine the efficacy, based on progression-free survival (PFS), of fluorouracil, oxaliplatin, and leucovorin calcium (modified [m]FOLFOX6)/bevacizumab plus atezolizumab (combination) as compared to single agent atezolizumab.
SECONDARY OBJECTIVES:
I. To compare the overall survival. II. To compare the objective response rates (ORR) per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1.
III. To determine the safety profiles of single agent atezolizumab and the combination of mFOLFOX6/bevacizumab/atezolizumab in patients with mismatch-repair deficient (dMMR)/microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC).
IV. To determine the duration of response. V. To determine the duration of stable disease. VI. To determine the rate of progression-free survival (PFS) at 12 months. VII. To evaluate the disease control rate (complete response [CR] + partial response [PR] + stable disease [SD]) at 12 months.
TRANSLATIONAL OBJECTIVE:
I. To bank tissue and blood samples for other future correlative studies from patients enrolled on the study.
OUTLINE: Patients are randomized to 1 of 3 arms.
ARM I (CLOSED TO ACCRUAL 6/4/2020): Patients receive bevacizumab intravenously (IV) over 30-90 minutes on day 1, oxaliplatin IV over 2 hours on day 1 of cycles 1-10, leucovorin calcium IV over 2 hours on day 1, and fluorouracil IV over 46-48 hours on days 1 and 2. Treatment with oxaliplatin repeats every 2 weeks for up to 10 cycles in the absence of disease progression or unacceptable toxicity. Treatment of bevacizumab, leucovorin calcium, and fluorouracil repeat every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo computed tomography (CT) with or without positron emission tomography (PET) or magnetic resonance imaging (MRI) throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial.
ARM II: Patients receive atezolizumab IV over 30-60 minutes on day 1. Treatment repeats every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial.
ARM III: Patients receive atezolizumab IV over 30-60 minutes on day 1. Treatment repeats every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients also receive bevacizumab IV over 30-90 minutes on day 1, oxaliplatin IV over 2 hours on day 1 cycles 1-10, leucovorin calcium IV over 2 hours on day 1, and fluorouracil IV over 46-48 hours on day 1. Treatment with oxaliplatin repeats every 2 weeks for up to 10 cycles in the absence of disease progression or unacceptable toxicity. Treatment of bevacizumab, leucovorin calcium, and fluorouracil repeat every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial.
After completion of study treatment, patients are followed up every 8 weeks for 18 months, and then every 12 weeks for up to 5 years.
Тип исследования
Регистрация (Оцененный)
Фаза
- Фаза 3
Контакты и местонахождение
Места учебы
-
-
Arizona
-
Kingman, Arizona, Соединенные Штаты, 86401
- Kingman Regional Medical Center
-
-
Arkansas
-
Jonesboro, Arkansas, Соединенные Штаты, 72401
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
-
-
California
-
Anaheim, California, Соединенные Штаты, 92806
- Kaiser Permanente-Anaheim
-
Baldwin Park, California, Соединенные Штаты, 91706
- Kaiser Permanente-Baldwin Park
-
Bellflower, California, Соединенные Штаты, 90706
- Kaiser Permanente-Bellflower
-
Berkeley, California, Соединенные Штаты, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Concord, California, Соединенные Штаты, 94520
- John Muir Medical Center-Concord
-
Fontana, California, Соединенные Штаты, 92335
- Kaiser Permanente-Fontana
-
Harbor City, California, Соединенные Штаты, 90710
- Kaiser Permanente South Bay
-
Irvine, California, Соединенные Штаты, 92618
- Kaiser Permanente-Irvine
-
Los Angeles, California, Соединенные Штаты, 90027
- Kaiser Permanente Los Angeles Medical Center
-
Los Angeles, California, Соединенные Штаты, 90034
- Kaiser Permanente West Los Angeles
-
Marysville, California, Соединенные Штаты, 95901
- Fremont - Rideout Cancer Center
-
Modesto, California, Соединенные Штаты, 95355
- Memorial Medical Center
-
Ontario, California, Соединенные Штаты, 91761
- Kaiser Permanente-Ontario
-
Orange, California, Соединенные Штаты, 92868
- UC Irvine Health/Chao Family Comprehensive Cancer Center
-
Orange, California, Соединенные Штаты, 92868
- Saint Joseph Hospital - Orange
-
Panorama City, California, Соединенные Штаты, 91402
- Kaiser Permanente - Panorama City
-
Riverside, California, Соединенные Штаты, 92505
- Kaiser Permanente-Riverside
-
Sacramento, California, Соединенные Штаты, 95816
- Sutter Medical Center Sacramento
-
Sacramento, California, Соединенные Штаты, 95817
- University of California Davis Comprehensive Cancer Center
-
Salinas, California, Соединенные Штаты, 93901
- Salinas Valley Memorial
-
San Diego, California, Соединенные Штаты, 92120
- Kaiser Permanente-San Diego Zion
-
San Diego, California, Соединенные Штаты, 92108
- Kaiser Permanente-Rio San Diego
-
San Marcos, California, Соединенные Штаты, 92078
- Kaiser Permanente-San Marcos
-
Walnut Creek, California, Соединенные Штаты, 94598
- John Muir Medical Center-Walnut Creek
-
Whittier, California, Соединенные Штаты, 90602
- Presbyterian Intercommunity Hospital
-
Woodland Hills, California, Соединенные Штаты, 91367
- Kaiser Permanente-Woodland Hills
-
-
Colorado
-
Aurora, Colorado, Соединенные Штаты, 80012
- Rocky Mountain Cancer Centers-Aurora
-
Aurora, Colorado, Соединенные Штаты, 80045
- UCHealth University of Colorado Hospital
-
Boulder, Colorado, Соединенные Штаты, 80303
- Boulder Community Foothills Hospital
-
Boulder, Colorado, Соединенные Штаты, 80304
- Rocky Mountain Cancer Centers-Boulder
-
Colorado Springs, Colorado, Соединенные Штаты, 80907
- Penrose-Saint Francis Healthcare
-
Colorado Springs, Colorado, Соединенные Штаты, 80909
- UCHealth Memorial Hospital Central
-
Colorado Springs, Colorado, Соединенные Штаты, 80920
- Memorial Hospital North
-
Denver, Colorado, Соединенные Штаты, 80218
- Rocky Mountain Cancer Centers-Midtown
-
Denver, Colorado, Соединенные Штаты, 80220
- Rocky Mountain Cancer Centers-Rose
-
Denver, Colorado, Соединенные Штаты, 80204
- Denver Health Medical Center
-
Denver, Colorado, Соединенные Штаты, 80206
- National Jewish Health-Main Campus
-
Denver, Colorado, Соединенные Штаты, 80218
- Saint Joseph Hospital - Cancer Centers of Colorado
-
Denver, Colorado, Соединенные Штаты, 80210
- AdventHealth Porter
-
Englewood, Colorado, Соединенные Штаты, 80113
- Mountain Blue Cancer Care Center - Swedish
-
Englewood, Colorado, Соединенные Штаты, 80113
- Swedish Medical Center
-
Fort Collins, Colorado, Соединенные Штаты, 80524
- Poudre Valley Hospital
-
Fort Collins, Colorado, Соединенные Штаты, 80528
- Cancer Care and Hematology-Fort Collins
-
Golden, Colorado, Соединенные Штаты, 80401
- National Jewish Health-Western Hematology Oncology
-
Greeley, Colorado, Соединенные Штаты, 80631
- UCHealth Greeley Hospital
-
Greeley, Colorado, Соединенные Штаты, 80631
- Banner North Colorado Medical Center
-
Littleton, Colorado, Соединенные Штаты, 80120
- Rocky Mountain Cancer Centers-Littleton
-
Lone Tree, Colorado, Соединенные Штаты, 80124
- Rocky Mountain Cancer Centers-Sky Ridge
-
Loveland, Colorado, Соединенные Штаты, 80538
- Medical Center of the Rockies
-
Loveland, Colorado, Соединенные Штаты, 80539
- Banner North Colorado Medical Center - Loveland Campus
-
Thornton, Colorado, Соединенные Штаты, 80260
- National Jewish Health-Northern Hematology Oncology
-
Wheat Ridge, Colorado, Соединенные Штаты, 80401
- Intermountain Health Lutheran Hospital
-
-
Connecticut
-
Danbury, Connecticut, Соединенные Штаты, 06810
- Danbury Hospital
-
Hartford, Connecticut, Соединенные Штаты, 06102
- Hartford Hospital
-
Meriden, Connecticut, Соединенные Штаты, 06451
- Midstate Medical Center
-
New Britain, Connecticut, Соединенные Штаты, 06050
- The Hospital of Central Connecticut
-
Norwich, Connecticut, Соединенные Штаты, 06360
- William Backus Hospital
-
-
Delaware
-
Millville, Delaware, Соединенные Штаты, 19967
- Beebe South Coastal Health Campus
-
Newark, Delaware, Соединенные Штаты, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, Соединенные Штаты, 19713
- Medical Oncology Hematology Consultants PA
-
Rehoboth Beach, Delaware, Соединенные Штаты, 19971
- Beebe Health Campus
-
-
District of Columbia
-
Washington D.C., District of Columbia, Соединенные Штаты, 20002
- Kaiser Permanente-Capitol Hill Medical Center
-
-
Florida
-
Fort Lauderdale, Florida, Соединенные Штаты, 33316
- Broward Health Medical Center
-
Fort Myers, Florida, Соединенные Штаты, 33905
- Regional Cancer Center-Lee Memorial Health System
-
Gainesville, Florida, Соединенные Штаты, 32610
- UF Health Cancer Institute - Gainesville
-
Jacksonville, Florida, Соединенные Штаты, 32207
- Baptist MD Anderson Cancer Center
-
Orlando, Florida, Соединенные Штаты, 32803
- AdventHealth Orlando
-
-
Georgia
-
Albany, Georgia, Соединенные Штаты, 31701
- Phoebe Putney Memorial Hospital
-
Athens, Georgia, Соединенные Штаты, 30607
- University Cancer and Blood Center LLC
-
Augusta, Georgia, Соединенные Штаты, 30912
- Augusta University Medical Center
-
Augusta, Georgia, Соединенные Штаты, 30901
- Augusta Oncology Associates PC-D'Antignac
-
Augusta, Georgia, Соединенные Штаты, 30909
- Augusta Oncology Associates PC-Wheeler
-
Newnan, Georgia, Соединенные Штаты, 30265
- CTCA at Southeastern Regional Medical Center
-
-
Idaho
-
Boise, Idaho, Соединенные Штаты, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
Boise, Idaho, Соединенные Штаты, 83712
- Saint Luke's Cancer Institute - Boise
-
Caldwell, Idaho, Соединенные Штаты, 83605
- Saint Alphonsus Cancer Care Center-Caldwell
-
Coeur d'Alene, Idaho, Соединенные Штаты, 83814
- Kootenai Health - Coeur d'Alene
-
Fruitland, Idaho, Соединенные Штаты, 83619
- Saint Luke's Cancer Institute - Fruitland
-
Meridian, Idaho, Соединенные Штаты, 83642
- Saint Luke's Cancer Institute - Meridian
-
Nampa, Idaho, Соединенные Штаты, 83687
- Saint Alphonsus Cancer Care Center-Nampa
-
Nampa, Idaho, Соединенные Штаты, 83687
- Saint Luke's Cancer Institute - Nampa
-
Post Falls, Idaho, Соединенные Штаты, 83854
- Kootenai Clinic Cancer Services - Post Falls
-
Sandpoint, Idaho, Соединенные Штаты, 83864
- Kootenai Clinic Cancer Services - Sandpoint
-
Twin Falls, Idaho, Соединенные Штаты, 83301
- Saint Luke's Cancer Institute - Twin Falls
-
-
Illinois
-
Bloomington, Illinois, Соединенные Штаты, 61704
- Illinois CancerCare-Bloomington
-
Canton, Illinois, Соединенные Штаты, 61520
- Illinois CancerCare-Canton
-
Carthage, Illinois, Соединенные Штаты, 62321
- Illinois CancerCare-Carthage
-
Centralia, Illinois, Соединенные Штаты, 62801
- Centralia Oncology Clinic
-
Chicago, Illinois, Соединенные Штаты, 60612
- University of Illinois
-
Chicago, Illinois, Соединенные Штаты, 60612
- Rush MD Anderson Cancer Center
-
Danville, Illinois, Соединенные Штаты, 61832
- Carle at The Riverfront
-
Decatur, Illinois, Соединенные Штаты, 62526
- Cancer Care Specialists of Illinois - Decatur
-
Dixon, Illinois, Соединенные Штаты, 61021
- Illinois CancerCare-Dixon
-
Effingham, Illinois, Соединенные Штаты, 62401
- Crossroads Cancer Center
-
Effingham, Illinois, Соединенные Штаты, 62401
- Carle Physician Group-Effingham
-
Eureka, Illinois, Соединенные Штаты, 61530
- Illinois CancerCare-Eureka
-
Evanston, Illinois, Соединенные Штаты, 60201
- NorthShore University HealthSystem-Evanston Hospital
-
Galesburg, Illinois, Соединенные Штаты, 61401
- Illinois CancerCare-Galesburg
-
Glenview, Illinois, Соединенные Штаты, 60026
- NorthShore University HealthSystem-Glenbrook Hospital
-
Highland Park, Illinois, Соединенные Штаты, 60035
- NorthShore University HealthSystem-Highland Park Hospital
-
Kewanee, Illinois, Соединенные Штаты, 61443
- Illinois CancerCare-Kewanee Clinic
-
Macomb, Illinois, Соединенные Штаты, 61455
- Illinois CancerCare-Macomb
-
Mattoon, Illinois, Соединенные Штаты, 61938
- Carle Physician Group-Mattoon/Charleston
-
Maywood, Illinois, Соединенные Штаты, 60153
- Loyola University Medical Center
-
Mount Vernon, Illinois, Соединенные Штаты, 62864
- SSM Health Good Samaritan
-
O'Fallon, Illinois, Соединенные Штаты, 62269
- Cancer Care Center of O'Fallon
-
Ottawa, Illinois, Соединенные Штаты, 61350
- Illinois CancerCare-Ottawa Clinic
-
Pekin, Illinois, Соединенные Штаты, 61554
- Illinois CancerCare-Pekin
-
Peoria, Illinois, Соединенные Штаты, 61615
- Illinois CancerCare-Peoria
-
Peru, Illinois, Соединенные Штаты, 61354
- Illinois CancerCare-Peru
-
Princeton, Illinois, Соединенные Штаты, 61356
- Illinois CancerCare-Princeton
-
Springfield, Illinois, Соединенные Штаты, 62702
- Southern Illinois University School of Medicine
-
Springfield, Illinois, Соединенные Штаты, 62702
- Springfield Clinic
-
Urbana, Illinois, Соединенные Штаты, 61801
- Carle Cancer Center
-
Washington, Illinois, Соединенные Штаты, 61571
- Illinois CancerCare - Washington
-
-
Indiana
-
Indianapolis, Indiana, Соединенные Штаты, 46237
- Franciscan Health Indianapolis
-
Indianapolis, Indiana, Соединенные Штаты, 46202
- Indiana University/Melvin and Bren Simon Cancer Center
-
Indianapolis, Indiana, Соединенные Штаты, 46219
- Community Cancer Center East
-
Indianapolis, Indiana, Соединенные Штаты, 46227
- Community Cancer Center South
-
Indianapolis, Indiana, Соединенные Штаты, 46256
- Community Cancer Center North
-
Kokomo, Indiana, Соединенные Штаты, 46904
- Community Howard Regional Health
-
Lafayette, Indiana, Соединенные Штаты, 47905
- Franciscan Saint Elizabeth Health - Lafayette East
-
Michigan City, Indiana, Соединенные Штаты, 46360
- Woodland Cancer Care Center
-
Mooresville, Indiana, Соединенные Штаты, 46158
- Franciscan Health Mooresville
-
Terre Haute, Indiana, Соединенные Штаты, 47804
- Union Hospital
-
-
Iowa
-
Ames, Iowa, Соединенные Штаты, 50010
- Mary Greeley Medical Center
-
Ames, Iowa, Соединенные Штаты, 50010
- McFarland Clinic - Ames
-
Bettendorf, Iowa, Соединенные Штаты, 52722
- University of Iowa Healthcare Cancer Services Quad Cities
-
Boone, Iowa, Соединенные Штаты, 50036
- McFarland Clinic - Boone
-
Cedar Rapids, Iowa, Соединенные Штаты, 52403
- Mercy Hospital
-
Cedar Rapids, Iowa, Соединенные Штаты, 52403
- Oncology Associates at Mercy Medical Center
-
Clive, Iowa, Соединенные Штаты, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, Соединенные Штаты, 50325
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic
-
Des Moines, Iowa, Соединенные Штаты, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Соединенные Штаты, 50314
- Broadlawns Medical Center
-
Des Moines, Iowa, Соединенные Штаты, 50309
- UI Health Care Mission Cancer and Blood - Des Moines Clinic
-
Des Moines, Iowa, Соединенные Штаты, 50314
- UI Health Care Mission Cancer and Blood - Laurel Clinic
-
Fort Dodge, Iowa, Соединенные Штаты, 50501
- McFarland Clinic - Trinity Cancer Center
-
Fort Dodge, Iowa, Соединенные Штаты, 50501
- UI Healthcare Mission Cancer and Blood - Fort Dodge
-
Iowa City, Iowa, Соединенные Штаты, 52242
- University of Iowa/Holden Comprehensive Cancer Center
-
Jefferson, Iowa, Соединенные Штаты, 50129
- McFarland Clinic - Jefferson
-
Marshalltown, Iowa, Соединенные Штаты, 50158
- McFarland Clinic - Marshalltown
-
West Des Moines, Iowa, Соединенные Штаты, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Hays, Kansas, Соединенные Штаты, 67601
- HaysMed
-
Lawrence, Kansas, Соединенные Штаты, 66044
- Lawrence Memorial Hospital
-
Olathe, Kansas, Соединенные Штаты, 66061
- The University of Kansas Cancer Center - Olathe
-
Salina, Kansas, Соединенные Штаты, 67401
- Salina Regional Health Center
-
Topeka, Kansas, Соединенные Штаты, 66606
- University of Kansas Health System Saint Francis Campus
-
Westwood, Kansas, Соединенные Штаты, 66205
- University of Kansas Hospital-Westwood Cancer Center
-
Wichita, Kansas, Соединенные Штаты, 67208
- Cancer Center of Kansas-Wichita Medical Arts Tower
-
Wichita, Kansas, Соединенные Штаты, 67214
- Cancer Center of Kansas - Wichita
-
-
Kentucky
-
Bardstown, Kentucky, Соединенные Штаты, 40004
- CommonSpirit Saint Joseph Hospital - Bardstown
-
Lexington, Kentucky, Соединенные Штаты, 40536
- University of Kentucky/Markey Cancer Center
-
Lexington, Kentucky, Соединенные Штаты, 40503
- Baptist Health Lexington
-
Lexington, Kentucky, Соединенные Штаты, 40509
- CommonSpirit Saint Joseph Medical Center - East Lexington
-
Louisville, Kentucky, Соединенные Штаты, 40202
- Norton Hospital Pavilion and Medical Campus
-
Louisville, Kentucky, Соединенные Штаты, 40241
- Norton Brownsboro Hospital and Medical Campus
-
Louisville, Kentucky, Соединенные Штаты, 40217
- Norton Audubon Hospital and Medical Campus
-
-
Louisiana
-
Kenner, Louisiana, Соединенные Штаты, 70065
- Ochsner Medical Center Kenner
-
New Orleans, Louisiana, Соединенные Штаты, 70121
- Ochsner Medical Center Jefferson
-
-
Maine
-
Augusta, Maine, Соединенные Штаты, 04330
- Harold Alfond Center for Cancer Care
-
Bangor, Maine, Соединенные Штаты, 04401
- Eastern Maine Medical Center
-
Belfast, Maine, Соединенные Штаты, 04915
- MaineHealth Waldo Hospital
-
Biddeford, Maine, Соединенные Штаты, 04005
- MaineHealth Maine Medical Center - Biddeford
-
Brewer, Maine, Соединенные Штаты, 04412
- Lafayette Family Cancer Center-EMMC
-
Rockport, Maine, Соединенные Штаты, 04856
- Penobscot Bay Medical Center
-
Sanford, Maine, Соединенные Штаты, 04073
- MaineHealth Cancer Care and IV Therapy - Sanford
-
South Portland, Maine, Соединенные Штаты, 04106
- MaineHealth Cancer Care and IV Therapy - South Portland
-
-
Maryland
-
Baltimore, Maryland, Соединенные Штаты, 21244
- Kaiser Permanente-Woodlawn Medical Center
-
Easton, Maryland, Соединенные Штаты, 21601
- University of Maryland Shore Medical Center at Easton
-
Gaithersburg, Maryland, Соединенные Штаты, 20879
- Kaiser Permanente-Gaithersburg Medical Center
-
Largo, Maryland, Соединенные Штаты, 20774
- Kaiser Permanente - Largo Medical Center
-
Lutherville, Maryland, Соединенные Штаты, 21093
- Kaiser Permanente Lutherville - Timonium Medical Center
-
-
Massachusetts
-
Boston, Massachusetts, Соединенные Штаты, 02215
- Dana-Farber Cancer Institute
-
Lowell, Massachusetts, Соединенные Штаты, 01854
- Lowell General Hospital
-
-
Michigan
-
Ann Arbor, Michigan, Соединенные Штаты, 48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Bay City, Michigan, Соединенные Штаты, 48706
- McLaren Cancer Institute-Bay City
-
Bloomfield, Michigan, Соединенные Штаты, 48302
- McLaren Cancer Institute-Bloomfield
-
Brighton, Michigan, Соединенные Штаты, 48114
- Trinity Health IHA Medical Group Hematology Oncology - Brighton
-
Brighton, Michigan, Соединенные Штаты, 48114
- Trinity Health Medical Center - Brighton
-
Brownstown, Michigan, Соединенные Штаты, 48183
- Henry Ford Cancer Institute-Downriver
-
Canton, Michigan, Соединенные Штаты, 48188
- Trinity Health IHA Medical Group Hematology Oncology - Canton
-
Canton, Michigan, Соединенные Штаты, 48188
- Trinity Health Medical Center - Canton
-
Chelsea, Michigan, Соединенные Штаты, 48118
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
-
Chelsea, Michigan, Соединенные Штаты, 48118
- Chelsea Hospital
-
Clarkston, Michigan, Соединенные Штаты, 48346
- McLaren Cancer Institute-Clarkston
-
Clarkston, Michigan, Соединенные Штаты, 48346
- Hematology Oncology Consultants-Clarkston
-
Clarkston, Michigan, Соединенные Штаты, 48346
- Newland Medical Associates-Clarkston
-
Clinton Township, Michigan, Соединенные Штаты, 48038
- Henry Ford Macomb Hospital-Clinton Township
-
Dearborn, Michigan, Соединенные Штаты, 48126
- Henry Ford Medical Center-Fairlane
-
Detroit, Michigan, Соединенные Штаты, 48202
- Henry Ford Hospital
-
Detroit, Michigan, Соединенные Штаты, 48201
- Wayne State University/Karmanos Cancer Institute
-
Farmington Hills, Michigan, Соединенные Штаты, 48334
- Weisberg Cancer Treatment Center
-
Flint, Michigan, Соединенные Штаты, 48532
- McLaren Cancer Institute-Flint
-
Flint, Michigan, Соединенные Штаты, 48532
- Singh and Arora Hematology Oncology PC
-
Grand Rapids, Michigan, Соединенные Штаты, 49503
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
-
Jackson, Michigan, Соединенные Штаты, 49201
- Allegiance Health
-
Kalamazoo, Michigan, Соединенные Штаты, 49007
- West Michigan Cancer Center
-
Lansing, Michigan, Соединенные Штаты, 48910
- Karmanos Cancer Institute at McLaren Greater Lansing
-
Lansing, Michigan, Соединенные Штаты, 48912
- University of Michigan Health - Sparrow Lansing
-
Lapeer, Michigan, Соединенные Штаты, 48446
- McLaren Cancer Institute-Lapeer Region
-
Livonia, Michigan, Соединенные Штаты, 48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Livonia, Michigan, Соединенные Штаты, 48154
- Hope Cancer Clinic
-
Mount Clemens, Michigan, Соединенные Штаты, 48043
- McLaren Cancer Institute-Macomb
-
Mount Pleasant, Michigan, Соединенные Штаты, 48858
- McLaren Cancer Institute-Central Michigan
-
Novi, Michigan, Соединенные Штаты, 48377
- Henry Ford Medical Center-Columbus
-
Petoskey, Michigan, Соединенные Штаты, 49770
- McLaren Cancer Institute-Northern Michigan
-
Pontiac, Michigan, Соединенные Штаты, 48341
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Pontiac, Michigan, Соединенные Штаты, 48341
- Trinity Health IHA Medical Group-Alice Gustafson Center
-
Port Huron, Michigan, Соединенные Штаты, 48060
- McLaren-Port Huron
-
Saginaw, Michigan, Соединенные Штаты, 48604
- Oncology Hematology Associates of Saginaw Valley PC
-
Saginaw, Michigan, Соединенные Штаты, 48601
- MyMichigan Medical Center Saginaw
-
Tawas City, Michigan, Соединенные Штаты, 48764
- MyMichigan Medical Center Tawas
-
Traverse City, Michigan, Соединенные Штаты, 49684
- Munson Medical Center
-
West Bloomfield, Michigan, Соединенные Штаты, 48322
- Henry Ford West Bloomfield Hospital
-
West Branch, Michigan, Соединенные Штаты, 48661
- Saint Mary's Oncology/Hematology Associates of West Branch
-
Ypsilanti, Michigan, Соединенные Штаты, 48197
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
-
-
Minnesota
-
Bemidji, Minnesota, Соединенные Штаты, 56601
- Sanford Joe Lueken Cancer Center
-
Burnsville, Minnesota, Соединенные Штаты, 55337
- Minnesota Oncology - Burnsville
-
Deer River, Minnesota, Соединенные Штаты, 56636
- Essentia Health - Deer River Clinic
-
Duluth, Minnesota, Соединенные Штаты, 55805
- Essentia Health Cancer Center
-
Hibbing, Minnesota, Соединенные Штаты, 55746
- Essentia Health Hibbing Clinic
-
Maplewood, Minnesota, Соединенные Штаты, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, Соединенные Штаты, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, Соединенные Штаты, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, Соединенные Штаты, 55454
- Health Partners Inc
-
Saint Paul, Minnesota, Соединенные Штаты, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Соединенные Штаты, 55102
- United Hospital
-
Sandstone, Minnesota, Соединенные Штаты, 55072
- Essentia Health Sandstone
-
Virginia, Minnesota, Соединенные Штаты, 55792
- Essentia Health Virginia Clinic
-
-
Mississippi
-
Grenada, Mississippi, Соединенные Штаты, 38901
- Baptist Cancer Center-Grenada
-
New Albany, Mississippi, Соединенные Штаты, 38652
- Baptist Memorial Hospital and Cancer Center-Union County
-
Oxford, Mississippi, Соединенные Штаты, 38655
- Baptist Memorial Hospital and Cancer Center-Oxford
-
Southhaven, Mississippi, Соединенные Штаты, 38671
- Baptist Memorial Hospital and Cancer Center-Desoto
-
-
Missouri
-
Ballwin, Missouri, Соединенные Штаты, 63011
- Mercy Oncology and Hematology - Clayton-Clarkson
-
Cape Girardeau, Missouri, Соединенные Штаты, 63703
- Saint Francis Medical Center
-
Columbia, Missouri, Соединенные Штаты, 65212
- MU Health - University Hospital/Ellis Fischel Cancer Center
-
Joplin, Missouri, Соединенные Штаты, 64804
- Freeman Health System
-
Joplin, Missouri, Соединенные Штаты, 64804
- Mercy Hospital Joplin
-
Kansas City, Missouri, Соединенные Штаты, 64108
- University Health Truman Medical Center
-
St Louis, Missouri, Соединенные Штаты, 63109
- Mercy Infusion Center - Chippewa
-
St Louis, Missouri, Соединенные Штаты, 63141
- Mercy Hospital Saint Louis
-
-
Montana
-
Anaconda, Montana, Соединенные Штаты, 59711
- Community Hospital of Anaconda
-
Billings, Montana, Соединенные Штаты, 59101
- Billings Clinic Cancer Center
-
Bozeman, Montana, Соединенные Штаты, 59715
- Bozeman Health Deaconess Hospital
-
Great Falls, Montana, Соединенные Штаты, 59405
- Great Falls Clinic
-
Great Falls, Montana, Соединенные Штаты, 59405
- Benefis Sletten Cancer Institute
-
Helena, Montana, Соединенные Штаты, 59601
- Saint Peter's Community Hospital
-
Kalispell, Montana, Соединенные Штаты, 59901
- Logan Health Medical Center
-
Missoula, Montana, Соединенные Штаты, 59804
- Community Medical Center
-
-
Nebraska
-
Omaha, Nebraska, Соединенные Штаты, 68114
- Nebraska Methodist Hospital
-
-
Nevada
-
Las Vegas, Nevada, Соединенные Штаты, 89102
- OptumCare Cancer Care at Charleston
-
Las Vegas, Nevada, Соединенные Штаты, 89128
- OptumCare Cancer Care at MountainView
-
Las Vegas, Nevada, Соединенные Штаты, 89183
- OptumCare Cancer Care at Fort Apache
-
Reno, Nevada, Соединенные Штаты, 89502
- Renown Regional Medical Center
-
-
New Hampshire
-
Lebanon, New Hampshire, Соединенные Штаты, 03756
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
-
Manchester, New Hampshire, Соединенные Штаты, 03104
- Dartmouth Cancer Center - Manchester/ DCC Manchester
-
Nashua, New Hampshire, Соединенные Штаты, 03063
- Dartmouth Cancer Center - Nashua
-
-
New Jersey
-
Hamilton, New Jersey, Соединенные Штаты, 08690
- The Cancer Institute of New Jersey Hamilton
-
Morristown, New Jersey, Соединенные Штаты, 07960
- Morristown Medical Center
-
New Brunswick, New Jersey, Соединенные Штаты, 08903
- Rutgers Cancer Institute of New Jersey
-
Paramus, New Jersey, Соединенные Штаты, 07652
- The Valley Hospital - Luckow Pavilion
-
Ridgewood, New Jersey, Соединенные Штаты, 07450
- Valley Health System Ridgewood Campus
-
Somerville, New Jersey, Соединенные Штаты, 08876
- Robert Wood Johnson University Hospital Somerset
-
Summit, New Jersey, Соединенные Штаты, 07902
- Overlook Hospital
-
-
New Mexico
-
Albuquerque, New Mexico, Соединенные Штаты, 87106
- University of New Mexico Cancer Center
-
Albuquerque, New Mexico, Соединенные Штаты, 87110
- Presbyterian Kaseman Hospital
-
Las Cruces, New Mexico, Соединенные Штаты, 88011
- Memorial Medical Center-Las Cruces
-
Rio Rancho, New Mexico, Соединенные Штаты, 87124
- Presbyterian Rust Medical Center/Jorgensen Cancer Center
-
-
New York
-
Buffalo, New York, Соединенные Штаты, 14263
- Roswell Park Cancer Institute
-
Elmira, New York, Соединенные Штаты, 14905
- Arnot Ogden Medical Center/Falck Cancer Center
-
Lake Success, New York, Соединенные Штаты, 11042
- Northwell Health/Center for Advanced Medicine
-
New York, New York, Соединенные Штаты, 10016
- Laura and Isaac Perlmutter Cancer Center at NYU Langone
-
Rochester, New York, Соединенные Штаты, 14642
- University of Rochester
-
White Plains, New York, Соединенные Штаты, 10601
- Dickstein Cancer Treatment Center
-
-
North Carolina
-
Chapel Hill, North Carolina, Соединенные Штаты, 27599
- UNC Lineberger Comprehensive Cancer Center
-
Clinton, North Carolina, Соединенные Штаты, 28328
- Southeastern Medical Oncology Center-Clinton
-
Goldsboro, North Carolina, Соединенные Штаты, 27534
- Southeastern Medical Oncology Center-Goldsboro
-
Hendersonville, North Carolina, Соединенные Штаты, 28791
- Margaret R Pardee Memorial Hospital
-
Jacksonville, North Carolina, Соединенные Штаты, 28546
- Southeastern Medical Oncology Center-Jacksonville
-
Kenansville, North Carolina, Соединенные Штаты, 28349
- ECU Health Oncology Kenansville
-
Kinston, North Carolina, Соединенные Штаты, 28501
- ECU Health Oncology Kinston
-
Pinehurst, North Carolina, Соединенные Штаты, 28374
- FirstHealth of the Carolinas-Moore Regional Hospital
-
Richlands, North Carolina, Соединенные Штаты, 28574
- ECU Health Oncology Richlands
-
Winston-Salem, North Carolina, Соединенные Штаты, 27157
- Wake Forest University Health Sciences
-
-
North Dakota
-
Bismarck, North Dakota, Соединенные Штаты, 58501
- Sanford Bismarck Medical Center
-
Fargo, North Dakota, Соединенные Штаты, 58122
- Sanford Roger Maris Cancer Center
-
Fargo, North Dakota, Соединенные Штаты, 58122
- Sanford Broadway Medical Center
-
Grand Forks, North Dakota, Соединенные Штаты, 58201
- Altru Cancer Center
-
-
Ohio
-
Akron, Ohio, Соединенные Штаты, 44307
- Cleveland Clinic Akron General
-
Belpre, Ohio, Соединенные Штаты, 45714
- Strecker Cancer Center-Belpre
-
Centerville, Ohio, Соединенные Штаты, 45459
- Miami Valley Hospital South
-
Centerville, Ohio, Соединенные Штаты, 45459
- Dayton Physicians LLC-Miami Valley South
-
Chillicothe, Ohio, Соединенные Штаты, 45601
- Adena Regional Medical Center
-
Cincinnati, Ohio, Соединенные Штаты, 45219
- University of Cincinnati Cancer Center-UC Medical Center
-
Cleveland, Ohio, Соединенные Штаты, 44111
- Cleveland Clinic Cancer Center/Fairview Hospital
-
Columbus, Ohio, Соединенные Штаты, 43214
- Riverside Methodist Hospital
-
Columbus, Ohio, Соединенные Штаты, 43210
- Ohio State University Comprehensive Cancer Center
-
Columbus, Ohio, Соединенные Штаты, 43219
- The Mark H Zangmeister Center
-
Columbus, Ohio, Соединенные Штаты, 43214
- Columbus Oncology and Hematology Associates Inc
-
Columbus, Ohio, Соединенные Штаты, 43228
- Doctors Hospital
-
Columbus, Ohio, Соединенные Штаты, 43213
- Mount Carmel East Hospital
-
Columbus, Ohio, Соединенные Штаты, 43215
- Grant Medical Center
-
Columbus, Ohio, Соединенные Штаты, 43222
- Mount Carmel Health Center West
-
Dayton, Ohio, Соединенные Штаты, 45409
- Miami Valley Hospital
-
Delaware, Ohio, Соединенные Штаты, 43015
- Delaware Health Center-Grady Cancer Center
-
Delaware, Ohio, Соединенные Штаты, 43015
- Grady Memorial Hospital
-
Kettering, Ohio, Соединенные Штаты, 45409
- Greater Dayton Cancer Center
-
Lancaster, Ohio, Соединенные Штаты, 43130
- Fairfield Medical Center
-
Mansfield, Ohio, Соединенные Штаты, 44906
- Cleveland Clinic Cancer Center Mansfield
-
Mansfield, Ohio, Соединенные Штаты, 44903
- OhioHealth Mansfield Hospital
-
Marietta, Ohio, Соединенные Штаты, 45750
- Marietta Memorial Hospital
-
Marion, Ohio, Соединенные Штаты, 43302
- OhioHealth Marion General Hospital
-
Mayfield Heights, Ohio, Соединенные Штаты, 44124
- Hillcrest Hospital Cancer Center
-
Mount Vernon, Ohio, Соединенные Штаты, 43050
- Knox Community Hospital
-
Newark, Ohio, Соединенные Штаты, 43055
- Licking Memorial Hospital
-
Portsmouth, Ohio, Соединенные Штаты, 45662
- Southern Ohio Medical Center
-
Sandusky, Ohio, Соединенные Штаты, 44870
- North Coast Cancer Care
-
Sylvania, Ohio, Соединенные Штаты, 43560
- ProMedica Flower Hospital
-
Warrensville Heights, Ohio, Соединенные Штаты, 44122
- South Pointe Hospital
-
West Chester, Ohio, Соединенные Штаты, 45069
- University of Cincinnati Cancer Center-West Chester
-
Westerville, Ohio, Соединенные Штаты, 43081
- Saint Ann's Hospital
-
Zanesville, Ohio, Соединенные Штаты, 43701
- Genesis Healthcare System Cancer Care Center
-
-
Oklahoma
-
Lawton, Oklahoma, Соединенные Штаты, 73505
- Cancer Centers of Southwest Oklahoma Research
-
Oklahoma City, Oklahoma, Соединенные Штаты, 73104
- University of Oklahoma Health Sciences Center
-
Tulsa, Oklahoma, Соединенные Штаты, 74146
- Oklahoma Cancer Specialists and Research Institute-Tulsa
-
Tulsa, Oklahoma, Соединенные Штаты, 74133
- Cancer Treatment Centers of America
-
-
Oregon
-
Bend, Oregon, Соединенные Штаты, 97701
- Saint Charles Health System
-
Clackamas, Oregon, Соединенные Штаты, 97015
- Clackamas Radiation Oncology Center
-
Clackamas, Oregon, Соединенные Штаты, 97015
- Providence Cancer Institute Clackamas Clinic
-
Newberg, Oregon, Соединенные Штаты, 97132
- Providence Newberg Medical Center
-
Ontario, Oregon, Соединенные Штаты, 97914
- Saint Alphonsus Cancer Care Center-Ontario
-
Oregon City, Oregon, Соединенные Штаты, 97045
- Providence Willamette Falls Medical Center
-
Portland, Oregon, Соединенные Штаты, 97213
- Providence Portland Medical Center
-
Portland, Oregon, Соединенные Штаты, 97225
- Providence Saint Vincent Medical Center
-
-
Pennsylvania
-
Allentown, Pennsylvania, Соединенные Штаты, 18103
- Lehigh Valley Hospital-Cedar Crest
-
Allentown, Pennsylvania, Соединенные Штаты, 18104
- Saint Luke's Cancer Center - Allentown
-
Bethlehem, Pennsylvania, Соединенные Штаты, 18017
- Lehigh Valley Hospital - Muhlenberg
-
Bethlehem, Pennsylvania, Соединенные Штаты, 18015
- Saint Luke's University Hospital-Bethlehem Campus
-
Easton, Pennsylvania, Соединенные Штаты, 18045
- Saint Luke's Hospital-Anderson Campus
-
Erie, Pennsylvania, Соединенные Штаты, 16544
- Saint Vincent Hospital
-
Harrisburg, Pennsylvania, Соединенные Штаты, 17109
- UPMC Pinnacle Cancer Center/Community Osteopathic Campus
-
Jefferson Hills, Pennsylvania, Соединенные Штаты, 15025
- Jefferson Hospital
-
Monroeville, Pennsylvania, Соединенные Штаты, 15146
- Forbes Hospital
-
Natrona Heights, Pennsylvania, Соединенные Штаты, 15065
- Allegheny Valley Hospital
-
Pittsburgh, Pennsylvania, Соединенные Штаты, 15212
- Allegheny General Hospital
-
Pittsburgh, Pennsylvania, Соединенные Штаты, 15224
- West Penn Hospital
-
Pittsburgh, Pennsylvania, Соединенные Штаты, 15232
- UPMC Hillman Cancer Center
-
Quakertown, Pennsylvania, Соединенные Штаты, 18951
- Saint Luke's Hospital-Quakertown Campus
-
West Reading, Pennsylvania, Соединенные Штаты, 19611
- Reading Hospital
-
Wexford, Pennsylvania, Соединенные Штаты, 15090
- Wexford Health and Wellness Pavilion
-
Willow Grove, Pennsylvania, Соединенные Штаты, 19090
- Asplundh Cancer Pavilion
-
-
South Carolina
-
Anderson, South Carolina, Соединенные Штаты, 29621
- AnMed Health Cancer Center
-
Beaufort, South Carolina, Соединенные Штаты, 29902
- Beaufort Memorial Hospital
-
Boiling Springs, South Carolina, Соединенные Штаты, 29316
- Prisma Health Cancer Institute - Spartanburg
-
Easley, South Carolina, Соединенные Штаты, 29640
- Prisma Health Cancer Institute - Easley
-
Greenville, South Carolina, Соединенные Штаты, 29605
- Prisma Health Cancer Institute - Faris
-
Greenville, South Carolina, Соединенные Штаты, 29607
- Saint Francis Cancer Center
-
Greenville, South Carolina, Соединенные Штаты, 29615
- Prisma Health Cancer Institute - Eastside
-
Greenville, South Carolina, Соединенные Штаты, 29605
- Prisma Health Cancer Institute - Butternut
-
Greenville, South Carolina, Соединенные Штаты, 29601
- Saint Francis Hospital
-
Greer, South Carolina, Соединенные Штаты, 29650
- Prisma Health Cancer Institute - Greer
-
Seneca, South Carolina, Соединенные Штаты, 29672
- Prisma Health Cancer Institute - Seneca
-
Spartanburg, South Carolina, Соединенные Штаты, 29303
- Spartanburg Medical Center
-
-
South Dakota
-
Aberdeen, South Dakota, Соединенные Штаты, 57401
- Avera Cancer Institute-Aberdeen
-
Sioux Falls, South Dakota, Соединенные Штаты, 57105
- Avera Cancer Institute
-
Sioux Falls, South Dakota, Соединенные Штаты, 57117-5134
- Sanford USD Medical Center - Sioux Falls
-
Sioux Falls, South Dakota, Соединенные Штаты, 57104
- Sanford Cancer Center Oncology Clinic
-
-
Tennessee
-
Bristol, Tennessee, Соединенные Штаты, 37620
- Bristol Regional Medical Center
-
Collierville, Tennessee, Соединенные Штаты, 38017
- Baptist Memorial Hospital and Cancer Center-Collierville
-
Cookeville, Tennessee, Соединенные Штаты, 38501
- Cookeville Regional Medical Center
-
Johnson City, Tennessee, Соединенные Штаты, 37604
- Wellmont Medical Associates Oncology and Hematology-Johnson City
-
Kingsport, Tennessee, Соединенные Штаты, 37660
- Ballad Health Cancer Care - Kingsport
-
Kingsport, Tennessee, Соединенные Штаты, 37660
- Wellmont Holston Valley Hospital and Medical Center
-
Memphis, Tennessee, Соединенные Штаты, 38120
- Baptist Memorial Hospital and Cancer Center-Memphis
-
-
Texas
-
Amarillo, Texas, Соединенные Штаты, 79106
- The Don and Sybil Harrington Cancer Center
-
Beaumont, Texas, Соединенные Штаты, 77701
- Baptist Hospitals of Southeast Texas Cancer Center
-
Conroe, Texas, Соединенные Штаты, 77384
- UT MD Anderson - The Woodlands
-
Dallas, Texas, Соединенные Штаты, 75235
- Parkland Memorial Hospital
-
Dallas, Texas, Соединенные Штаты, 75390
- UT Southwestern/Simmons Cancer Center-Dallas
-
Edinburg, Texas, Соединенные Штаты, 78539
- STCC at DHR Health Institute for Research and Development
-
Houston, Texas, Соединенные Штаты, 77026-1967
- Lyndon Baines Johnson General Hospital
-
Houston, Texas, Соединенные Штаты, 77030
- UT MD Anderson Cancer Center
-
Houston, Texas, Соединенные Штаты, 77030
- Houston Methodist Hospital
-
Houston, Texas, Соединенные Штаты, 77079
- UT MD Anderson - West Houston
-
League City, Texas, Соединенные Штаты, 77573
- UT MD Anderson - League City
-
Port Arthur, Texas, Соединенные Штаты, 77642
- Baptist Regional Cancer Network-Cancer Center of Southeast Texas
-
Sugar Land, Texas, Соединенные Штаты, 77478
- UT MD Anderson - Sugar Land
-
Temple, Texas, Соединенные Штаты, 76508
- Scott and White Memorial Hospital
-
-
Utah
-
Salt Lake City, Utah, Соединенные Штаты, 84112
- Huntsman Cancer Institute/University of Utah
-
-
Vermont
-
Saint Johnsbury, Vermont, Соединенные Штаты, 05819
- Dartmouth Cancer Center - North
-
-
Virginia
-
Bristol, Virginia, Соединенные Штаты, 24201
- Ballad Health Cancer Care - Bristol
-
Burke, Virginia, Соединенные Штаты, 22015
- Kaiser Permanente-Burke Medical Center
-
Fishersville, Virginia, Соединенные Штаты, 22939
- Augusta Health Center for Cancer and Blood Disorders
-
Lynchburg, Virginia, Соединенные Штаты, 24501
- Centra Alan B Pearson Regional Cancer Center
-
McLean, Virginia, Соединенные Штаты, 22102
- Kaiser Permanente Tysons Corner Medical Center
-
Norton, Virginia, Соединенные Штаты, 24273
- Ballad Health Cancer Care - Norton
-
Richmond, Virginia, Соединенные Штаты, 23235
- VCU Massey Cancer Center at Stony Point
-
Richmond, Virginia, Соединенные Штаты, 23229
- Virginia Cancer Institute
-
Richmond, Virginia, Соединенные Штаты, 23298
- VCU Massey Comprehensive Cancer Center
-
South Hill, Virginia, Соединенные Штаты, 23970
- VCU Community Memorial Health Center
-
Woodbridge, Virginia, Соединенные Штаты, 22192
- Kaiser Permanente-Caton Hill Medical Center
-
-
Washington
-
Edmonds, Washington, Соединенные Штаты, 98026
- Swedish Cancer Institute-Edmonds
-
Issaquah, Washington, Соединенные Штаты, 98029
- Swedish Cancer Institute-Issaquah
-
Port Townsend, Washington, Соединенные Штаты, 98368
- Jefferson Healthcare
-
Seattle, Washington, Соединенные Штаты, 98122
- Swedish Medical Center-First Hill
-
Spokane, Washington, Соединенные Штаты, 99204
- MultiCare Deaconess Cancer and Blood Specialty Center - Downtown
-
Spokane, Washington, Соединенные Штаты, 99218
- MultiCare Deaconess Cancer and Blood Specialty Center - North
-
-
West Virginia
-
Charleston, West Virginia, Соединенные Штаты, 25304
- Vandalia Health/CAMC Institute for Academic Medicine
-
Morgantown, West Virginia, Соединенные Штаты, 26506
- West Virginia University Healthcare
-
Parkersburg, West Virginia, Соединенные Штаты, 26101
- Camden Clark Medical Center
-
-
Wisconsin
-
Antigo, Wisconsin, Соединенные Штаты, 54409
- Aspirus Cancer Care-Antigo-Volm Cancer Center
-
Appleton, Wisconsin, Соединенные Штаты, 54911
- ThedaCare Regional Cancer Center
-
Appleton, Wisconsin, Соединенные Штаты, 54915
- Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton
-
Ashland, Wisconsin, Соединенные Штаты, 54806
- Duluth Clinic Ashland
-
Brookfield, Wisconsin, Соединенные Штаты, 53045
- Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield
-
Eau Claire, Wisconsin, Соединенные Штаты, 54701
- Marshfield Medical Center-EC Cancer Center
-
Franklin, Wisconsin, Соединенные Штаты, 53132
- Reiman Cancer Center-Ascension Wisconsin Health Center-Rawson
-
Green Bay, Wisconsin, Соединенные Штаты, 54301
- Bellin Memorial Hospital
-
Janesville, Wisconsin, Соединенные Штаты, 53548
- Mercyhealth Hospital and Cancer Center - Janesville
-
Johnson Creek, Wisconsin, Соединенные Штаты, 53038
- University of Wisconsin Carbone Cancer Center - Johnson Creek
-
La Crosse, Wisconsin, Соединенные Штаты, 54601
- Gundersen Lutheran Medical Center
-
Madison, Wisconsin, Соединенные Штаты, 53792
- University of Wisconsin Carbone Cancer Center - University Hospital
-
Madison, Wisconsin, Соединенные Штаты, 53718
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
-
Marshfield, Wisconsin, Соединенные Штаты, 54449
- Marshfield Medical Center-Marshfield
-
Medford, Wisconsin, Соединенные Штаты, 54451
- Aspirus Medford Hospital
-
Minocqua, Wisconsin, Соединенные Штаты, 54548
- Marshfield Medical Center - Minocqua
-
Mukwonago, Wisconsin, Соединенные Штаты, 53149
- ProHealth D N Greenwald Center
-
New Richmond, Wisconsin, Соединенные Штаты, 54017
- Cancer Center of Western Wisconsin
-
Oconomowoc, Wisconsin, Соединенные Штаты, 53066
- ProHealth Oconomowoc Memorial Hospital
-
Oshkosh, Wisconsin, Соединенные Штаты, 54904
- Ascension Northeast Wisconsin-Mercy Hospital-Oshkosh
-
Racine, Wisconsin, Соединенные Штаты, 53405
- Ascension All Saints Hospital-Spring Street-Racine
-
Rhinelander, Wisconsin, Соединенные Штаты, 54501
- Aspirus Cancer Care-Rhinelander-James Beck Cancer Center
-
Rice Lake, Wisconsin, Соединенные Штаты, 54868
- Marshfield Medical Center-Rice Lake
-
Stevens Point, Wisconsin, Соединенные Штаты, 54482
- Marshfield Medical Center-River Region at Stevens Point
-
Waukesha, Wisconsin, Соединенные Штаты, 53188
- UW Cancer Center at ProHealth Care
-
Waukesha, Wisconsin, Соединенные Штаты, 53188
- ProHealth Waukesha Memorial Hospital
-
Wausau, Wisconsin, Соединенные Штаты, 54401
- Aspirus Cancer Care-Wausau
-
Wauwatosa, Wisconsin, Соединенные Штаты, 53226
- Ascension Southeast Wisconsin Hospital-Mayfair Road-Wauwatosa
-
Weston, Wisconsin, Соединенные Штаты, 54476
- Marshfield Medical Center - Weston
-
Wisconsin Rapids, Wisconsin, Соединенные Штаты, 54494
- Aspirus Cancer Care - Wisconsin Rapids
-
-
Wyoming
-
Cheyenne, Wyoming, Соединенные Штаты, 82001
- Cheyenne Regional Medical Center-West
-
Cody, Wyoming, Соединенные Штаты, 82414
- Billings Clinic-Cody
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
-
The patient must have signed and dated an Institutional Review Board (IRB)-approved consent form that conforms to federal and institutional guidelines
-
Age >= 18 years
-
Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2
-
Diagnosis of metastatic adenocarcinoma of colon or rectum without previous chemotherapy or any other systemic therapy for metastatic colorectal cancer except for one cycle of FOLFOX or capecitabine and oxaliplatin (CAPOX), either with or without bevacizumab prior to enrollment. Upon enrollment, the preceding single cycle of FOLFOX or FOLFOX + bevacizumab, if the patient received one, will not count towards patients' assessments per protocol. Cycle 1 day 1 (C1D1) of atezolizumab or C1D1 of mFOLFOX6/bevacizumab + atezolizumab will correspond to the first day the patient received therapy on trial
-
Tumor determined to be mismatch-repair deficient (dMMR) by Clinical Laboratory Improvement Act (CLIA)-certified immunohistochemical (IHC) assay with a panel of all four IHC markers, including MLH1, MSH2, PMS2, and MSH6; alternatively, MSI-H diagnosed by polymerase chain reaction (PCR)-based assessment of microsatellite alterations (either Bethesda markers or Pentaplex panel) or by next-generation sequencing (NGS) are eligible
-
Documentation by PET/CT scan, CT scan, or MRI that the patient has measurable metastatic disease per RECIST 1.1
-
No immediate need for surgical intervention for the primary tumor or palliative diversion/bypass
-
Absolute neutrophil count (ANC) must be >= 1500/mm^3 (obtained within 28 days prior randomization)
-
Platelet count must be >= 100,000/mm^3 (obtained within 28 days prior randomization)
-
Hemoglobin must be >= 8 g/dL (obtained within 28 days prior randomization)
-
Total bilirubin must be =< 4 x ULN (upper limit of normal) (obtained within 28 days prior randomization); and
-
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) must be =< 3 x ULN for the lab with the following exception: for patients with documented liver metastases, AST and ALT must be =< 5 x ULN (obtained within 28 days prior randomization)
-
Calculated creatinine clearance >= 30 mL/min (obtained within 28 days prior randomization)
-
A urine sample tested for proteinuria by either the dipstick method, urinalysis (UA), or a urine protein creatinine (UPC) ratio:
- The dipstick method must indicate 0-1+ protein; if dipstick reading is >= 2+, a 24-hour urine must be done and it must demonstrate < 1.0 g of protein per 24 hours or a UPC ratio < 1.0
- A urine protein creatinine (UPC) ratio must be < 1.0; if the UPC ratio is >= 1.0 a 24-hour urine must be done and it must demonstrate < 1.0 g of protein per 24 hours
- Urinalysis must indicate < 30 mg/dl. If urinalysis >= 30 mg/dl, a 24-hour urine must be done and it must demonstrate < 1.0 g of protein per 24 hours or a UPC ratio < 1.0
-
International normalized ratio of prothrombin time (INR) and prothrombin time (PT) must be =< 1.5 x ULN for the lab within 28 days before randomization; patients who are therapeutically treated with an agent such as warfarin may participate if they are on a stable dose and no underlying abnormality in coagulation parameters exists per medical history, regardless of PT/INR results
-
Pregnancy test done within 28 days prior randomization must be negative (for women of childbearing potential only); pregnancy testing should be performed according to institutional standards; administration of atezolizumab or mFOLFOX6/bevacizumab/atezolizumab may have an adverse effect on pregnancy and poses a risk to the human fetus, including embryo-lethality; should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she should inform her treating physician immediately
-
Women of child-bearing potential and men must agree to use adequate contraception methods that result in a failure rate of < 1% per year during the treatment period (hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of study participation, and for 5 months (150 days) after the last dose of atezolizumab, 6 months after the last dose of bevacizumab, and 6 months after the last dose of mFOLFOX6; a woman is considered to be of childbearing potential if she is not postmenopausal, has not reached a postmenopausal state (>= 12 continuous months of amenorrhea with no identified cause other than menopause), and has not undergone surgical sterilization (removal of ovaries and/or uterus); examples of contraceptive methods with a failure rate of < 1% per year include: bilateral tubal ligation; male partner sterilization; intrauterine devices; the reliability of sexual abstinence should be evaluated in relation to the duration of the clinical study and the preferred and usual lifestyle of the patient; periodic abstinence (e.g., calendar, ovulation, symptothermal, or postovulation methods) and withdrawal are not acceptable methods of contraception; men must refrain from donating sperm during this same period
Exclusion Criteria:
-
Known hypersensitivity to Chinese hamster ovary cell products or other recombinant human antibodies, fluoropyrimidines, folic acid derivatives or oxaliplatin
-
Uncontrolled high blood pressure defined as systolic blood pressure (BP) > 150 mmHg or diastolic BP > 100 mmHg with or without anti-hypertensive medication; patients with initial BP elevations are eligible if initiation or adjustment of BP medication lowers pressure to meet entry criteria
-
Documented New York Heart Association (NYHA) class III or IV congestive heart failure
-
Serious or non-healing wound, skin ulcer, or bone fracture
-
History of inherited bleeding diathesis, gastrointestinal (GI) perforation, significant vascular disease (e.g., aortic aneurysm requiring surgical repair or recent arterial thrombosis or symptomatic peripheral ischemia, transient ischemic attack [TIA], cerebrovascular accident [CVA] or arterial thrombotic event), abdominal fistula, intra-abdominal abscess, or active GI bleeding (with cause not addressed) within 6 months prior to randomization, or other medical condition in the opinion of the treating oncologist that makes the risk of cardiovascular or bleeding complications with bevacizumab use unacceptably high
-
Other malignancies are excluded unless the patient has completed therapy for the malignancy >= 12 months prior to randomization and is considered disease-free; patients with the following cancers are eligible if diagnosed and treated within the past 12 months: in situ carcinomas or basal cell and squamous cell carcinoma of the skin
-
Known DPD (dihydro pyrimidine dehydrogenase) deficiency
-
Symptomatic peripheral sensory neuropathy >= grade 2 (Common Terminology Criteria for Adverse Events [CTCAE] version [v] 5.0)
-
Prior treatment with oxaliplatin chemotherapy within 6 months prior to randomization
-
History of grade 2 hemoptysis (defined as 2.5 mL of bright red blood per episode) within 1 month prior to screening
-
Prior treatment with anti-PD-1, or anti-PD-L1 therapeutic antibody or pathway-targeting agents; patients who have received prior treatment with anti-CTLA-4 may be enrolled provided the following requirements are met:
- Minimum of 12 weeks from the first dose of anti-CTLA-4 and > 6 weeks from the last dose to randomization
- No history of severe immune-related adverse effects (CTCAE grade 3 and 4) from anti-CTLA-4
-
Treatment with systemic immunosuppressive medications (including, but not limited to, prednisone, cyclophosphamide, azathioprine, methotrexate, thalidomide, and anti-tumor necrosis factor [anti-TNF] agents) within 14 days prior to randomization; however,
- Patients who have received acute, low dose, systemic immunosuppressant medications (e.g., a one-time dose of dexamethasone for nausea; or chronic daily treatment with corticosteroids with a dose of =< 10 mg/day methylprednisolone equivalent) may be enrolled
- The use of inhaled corticosteroids and mineralocorticoids (e.g., fludrocortisone) for patients with orthostatic hypotension or adrenocortical insufficiency is allowed
-
Known clinically significant liver disease, including active viral, alcoholic, or other hepatitis; cirrhosis; fatty liver; and inherited liver disease; however,
- Patients with past or resolved hepatitis B infection (defined as having a negative hepatitis B surface antigen [HbsAg] test and a positive anti-HBc [antibody to hepatitis B core antigen] antibody test) are eligible if polymerase chain reaction (PCR) for hepatits B virus (HBV) ribonucleic acid (RNA) is negative per local guidelines
- Patients positive for hepatitis C virus (HCV) antibody are eligible only if polymerase chain reaction (PCR) is negative for HCV RNA per local guidelines
-
History or risk of autoimmune disease, including, but not limited to, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vascular thrombosis associated with antiphospholipid syndrome, Wegener's granulomatosis, Sjogren's syndrome, Bell's palsy, Guillain-Barre syndrome, multiple sclerosis, autoimmune thyroid disease, vasculitis, or glomerulonephritis; however,
-
Patients with a history of autoimmune hypothyroidism on a stable dose of thyroid replacement hormone may be eligible
-
Patients with controlled type 1 diabetes mellitus on a stable insulin regimen may be eligible
-
Patients with eczema, psoriasis, lichen simplex chronicus or vitiligo with dermatologic manifestations only (e.g., patients with psoriatic arthritis would be excluded) are permitted provided that they meet the following conditions:
- Patients with psoriasis must have a baseline ophthalmologic exam to rule out ocular manifestations
- Rash must cover less than 10% of body surface area (BSA)
- Disease is well controlled at baseline and only requiring low potency topical steroids (e.g., hydrocortisone 2.5%, hydrocortisone butyrate 0.1%, fluocinolone 0.01%, desonide 0.05%, alclometasone dipropionate 0.05%)
- No acute exacerbations of underlying condition within the last 12 months (not requiring psoralen plus ultraviolet A radiation [PUVA], methotrexate, retinoids, biologic agents, oral calcineurin inhibitors; high potency or oral steroids)
-
-
History of idiopathic pulmonary fibrosis, organizing pneumonia (i.e., bronchiolitis obliterans, cryptogenic organizing pneumonia, etc.), or active or recently active (within 90 days of randomization) pneumonitis (including drug induced) that required systemic immunosuppressive therapy (i.e. corticosteroids, etc.). History of radiation pneumonitis in the radiation field (fibrosis) is permitted
-
History of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric or humanized antibodies or fusion proteins
-
Patients with known active tuberculosis (TB) are excluded
-
Severe infections within 28 days prior to randomization, including but not limited to, hospitalization for complications of infection, bacteremia, or severe pneumonia
-
Signs or symptoms of infection within 14 days prior to randomization
-
Received oral or intravenous (IV) antibiotics within 14 days prior to randomization; patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible
-
Major surgical procedure, open biopsy, or significant traumatic injury within 28 days prior to randomization or anticipation of need for a major surgical procedure during the course of the study
-
The administration of a live, attenuated vaccine within 28 days prior to randomization
-
Pregnant women are excluded from this study because atezolizumab is an agent with the potential for teratogenic or abortifacient effects; because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother with atezolizumab, breastfeeding should be discontinued if the mother is treated with atezolizumab; these potential risks may also apply to other agents used in this study; (Note: pregnancy testing should be performed within 28 days prior to randomization according to institutional standards for women of childbearing potential)
-
Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial
-
Patients with prior allogeneic bone marrow transplantation or prior solid organ transplantation
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Уход
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Нет (открытая этикетка)
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Активный компаратор: Arm I (bevacizumab, mFOLFOX6)
Patients receive bevacizumab intravenously (IV) over 30-90 minutes on day 1, oxaliplatin IV over 2 hours on day 1 of cycles 1-10, leucovorin calcium IV over 2 hours on day 1, and fluorouracil IV over 46-48 hours on days 1 and 2. Treatment with oxaliplatin repeats every 2 weeks for up to 10 cycles in the absence of disease progression or unacceptable toxicity. Treatment of bevacizumab, leucovorin calcium, and fluorouracil repeat every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial. (CLOSED TO ACCRUAL) |
Ancillary studies
Другие имена:
Given IV
Другие имена:
Given IV
Другие имена:
Undergo MRI
Другие имена:
Ancillary studies Undergo collection of blood samples
Другие имена:
Given IV
Другие имена:
Undergo CT or CT/PET
Другие имена:
Given IV
Другие имена:
Undergo CT/PET
Другие имена:
|
|
Экспериментальный: Arm II (atezolizumab)
Patients receive atezolizumab IV over 30-60 minutes on day 1. Treatment repeats every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial. |
Ancillary studies
Другие имена:
Undergo MRI
Другие имена:
Ancillary studies Undergo collection of blood samples
Другие имена:
Given IV
Другие имена:
Undergo CT or CT/PET
Другие имена:
Undergo CT/PET
Другие имена:
|
|
Экспериментальный: Arm III (atezolizumab, bevacizumab, mFOLFOX6)
Patients receive atezolizumab IV over 30-60 minutes on day 1. Treatment repeats every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients also receive bevacizumab IV over 30-90 minutes on day 1, oxaliplatin IV over 2 hours on day 1 cycles 1-10, leucovorin calcium IV over 2 hours on day 1, and fluorouracil IV over 46-48 hours on day 1. Treatment with oxaliplatin repeats every 2 weeks for up to 10 cycles in the absence of disease progression or unacceptable toxicity. Treatment of bevacizumab, leucovorin calcium, and fluorouracil repeat every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial. |
Ancillary studies
Другие имена:
Given IV
Другие имена:
Given IV
Другие имена:
Undergo MRI
Другие имена:
Ancillary studies Undergo collection of blood samples
Другие имена:
Given IV
Другие имена:
Given IV
Другие имена:
Undergo CT or CT/PET
Другие имена:
Given IV
Другие имена:
Undergo CT/PET
Другие имена:
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Progression free survival (PFS)
Временное ограничение: From the time from randomization until first confirmed progression or death from any cause, assessed up to 5 years
|
The analysis set is intent-to-treat (ITT). The experimental arms will be compared to the control arm by the log-rank test stratified by BRAF status (V600E mutation or not), metastatic disease: (liver-only, extra-hepatic), and prior adjuvant therapy for colon cancer (yes, no). Hazard ratios and associated confidence intervals from a stratified Cox regression model will also be reported along with estimates of the distributions of time to PFS event by the method of Kaplan and Meier. Sensitivity analyses accounting for 2 or more consecutively missed scheduled tumor imaging scans before progression/death will also be conducted. |
From the time from randomization until first confirmed progression or death from any cause, assessed up to 5 years
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Скорость ВБП
Временное ограничение: В 12 месяцев
|
В 12 месяцев
|
|
|
Overall survival (OS)
Временное ограничение: The time from randomization to death from any cause, assessed up to 5 years
|
Will be analyzed using the stratified log rank test and the ITT population. Kaplan-Meier plots will illustrate the distribution of these endpoints by treatment. Stratified Cox regression models will be used to estimate hazard ratios and associated confidence intervals. |
The time from randomization to death from any cause, assessed up to 5 years
|
|
Objective response rate (ORR) (complete response [CR] or partial response [PR])
Временное ограничение: Up to 5 years
|
Assessed by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1. Will be analyzed by a logistic regression models that control for the stratification factors (BRAF status, liver involvement, and adjuvant chemotherapy [chemo]) using the ITT population. Observed proportions along with confidence intervals will be presented by treatment. |
Up to 5 years
|
|
Incidence of adverse events
Временное ограничение: Up to 30 days after last cycle
|
Defined by Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. The safety profile will be described by tabulating the maximum observed grade of adverse event for each individual adverse event, for each system organ class, and overall using the Safety population. |
Up to 30 days after last cycle
|
|
Disease control rate (CR + PR + stable disease [SD])
Временное ограничение: At 12 months
|
Assessed by RECIST 1.1. Will be analyzed by a logistic regression models that control for the stratification factors (BRAF status, liver involvement, and adjuvant chemo) using the ITT population. Observed proportions along with confidence intervals will be presented by treatment. |
At 12 months
|
|
Duration of overall response (CR or PR)
Временное ограничение: From the time of first response to first confirmed progression by the study investigator or death from any cause, assessed up to 5 years
|
Assessed by RECIST 1.1. Will be analyzed using the stratified log rank test and the ITT population. Kaplan-Meier plots will illustrate the distribution of these endpoints by treatment. Stratified Cox regression models will be used to estimate hazard ratios and associated confidence intervals. |
From the time of first response to first confirmed progression by the study investigator or death from any cause, assessed up to 5 years
|
|
Duration of SD
Временное ограничение: From the time of first on-study assessment of SD to first progression by the study investigator or death from any cause, assessed up to 5 years
|
Assessed per RECIST 1.1. Will be analyzed using the stratified log rank test and the ITT population. Kaplan-Meier plots will illustrate the distribution of these endpoints by treatment. Stratified Cox regression models will be used to estimate hazard ratios and associated confidence intervals. |
From the time of first on-study assessment of SD to first progression by the study investigator or death from any cause, assessed up to 5 years
|
Другие показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Severity of fatigue
Временное ограничение: At 16 weeks
|
Will use the ITT population. Measured by the Patient Reported Outcomes Measurement Information System (PROMIS) Fatigue questionnaire. Will be compared between the control arm (Chemo-bevacizumab [Bev]) and the experimental arm by means of ordinal logistic regression with adjustment for the corresponding baseline measurement and stratification variables. The comparison will be performed at the significance level of 0.05 (two-sided) and the clinical meaningfulness of the comparison will be considered. |
At 16 weeks
|
|
Physical functioning
Временное ограничение: At 16 weeks
|
Will use the ITT population. Measured by the European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire (QLQ)-C30 physical functioning scale. Will be compared between the control arm (Chemo-Bev) and the experimental arm by means of ordinal logistic regression with adjustment for the corresponding baseline measurement and stratification variables. The comparison will be performed at the significance level of 0.05 (two-sided) and the clinical meaningfulness of the comparison will be considered. |
At 16 weeks
|
|
Health utility scores
Временное ограничение: Up to 5 years
|
Will use the ITT population. Will be measured using the EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) questionnaire. |
Up to 5 years
|
|
Proportion of patients reporting each response option at each assessment timepoint by treatment arm for item GP5 from the Functional Assessment of Cancer Therapy - General (FACT-G)
Временное ограничение: Up to 5 years
|
Will use the ITT population. |
Up to 5 years
|
|
Intratumoral lymphocyte PD-L1+ expression (>= 1 % is positive) by immunohistochemistry (IHC) as a predictive biomarker of efficacy
Временное ограничение: Up to 5 years
|
Will use the ITT population. |
Up to 5 years
|
|
Efficacy dependent on the number of somatic mutations
Временное ограничение: Up to 5 years
|
Will use the ITT population. |
Up to 5 years
|
|
Efficacy in tumors with MLH1 silencing
Временное ограничение: Up to 5 years
|
Will use the ITT population. |
Up to 5 years
|
|
Change in quantification of cell free deoxyribonucleic acid (cfDNA) mutations
Временное ограничение: Baseline up to 5 years
|
Will use the ITT population. |
Baseline up to 5 years
|
|
Development of progression or relapse to treatment in cfDNA
Временное ограничение: Up to 5 years
|
Will use the ITT population. |
Up to 5 years
|
|
Changes in T-cell repertoire diversity as a predictive biomarker of efficacy
Временное ограничение: Baseline up to 5 years
|
Will use the ITT population. |
Baseline up to 5 years
|
|
PFS of patients with high levels of diversity
Временное ограничение: Up to 5 years
|
Compared to patients with low levels of diversity. Will use the ITT population. |
Up to 5 years
|
|
Change in T-cell diversity
Временное ограничение: Baseline to first restaging between immunotherapy arms and the standard of care arm
|
Will use the ITT population. |
Baseline to first restaging between immunotherapy arms and the standard of care arm
|
|
Mechanism of immune resistance to PD-1 blockade in mismatch repair deficient (dMMR)/microsatellite instability-high metastatic colorectal cancer (mCRC) by comparative analysis of tumor samples collected
Временное ограничение: Baseline up to 5 years
|
Will use the ITT population. |
Baseline up to 5 years
|
Соавторы и исследователи
Спонсор
Следователи
- Главный следователь: Caio Max S Rocha Lima, NRG Oncology
Публикации и полезные ссылки
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Оцененный)
Завершение исследования (Оцененный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Оцененный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Дополнительные соответствующие термины MeSH
- Новообразования по локализации
- Новообразования
- Кишечные заболевания
- Желудочно-кишечные новообразования
- Новообразования пищеварительной системы
- Заболевания пищеварительной системы
- Желудочно-кишечные заболевания
- Новообразования кишечника
- Заболевания прямой кишки
- Заболевания толстой кишки
- Колоректальные новообразования
- Аминокислоты, пептиды и белки
- Белки
- Средние соединения
- Органические химические вещества
- Гетероциклические соединения, 1-кольцо
- Гетероциклические соединения
- Гетероциклические соединения, 2-кольцо
- Гетероциклические соединения, слитое кольцо
- Следственные методы
- Клинические лабораторные методы
- Диагностические методы и процедуры
- Диагноз
- Ферменты и коэнзименты
- Антитела, моноклональные, гуманизированные
- Антитела, моноклональные
- Антитела
- Иммуноглобулины
- Иммунопротеины
- Белки крови
- Сывороточные глобулины
- Глобулины
- Неорганические химические вещества
- Координационные комплексы
- Пиримидины
- Химические методы, аналитические
- Анализ спектра
- Формилтетрагидрофолаты
- Тетрагидрофолаты
- Фолиевая кислота
- Птерины
- Птеридины
- Урацил
- Пиримидиноны
- Коэнзименты
- Изотиотипы иммуноглобулина
- Сульфиды
- Анионы
- Ионы
- Электролиты
- Сероводород
- Оксалиплатин
- Бевацизумаб
- Фторурацил
- Лейковорин
- Иммуноглобулин G
- Обработка образца
- Магнитно -резонансная спектроскопия
- Дисульфиды
- Атезолизумаб
- Dehydroftorafur
Другие идентификационные номера исследования
- NCI-2016-01961
- U10CA180868 (Грант/контракт NIH США)
- NCI-2016-01961 (Идентификатор реестра: CTRP (Clinical Trial Reporting Program))
- NRG-GI004/S1610
- NRG-GI004 (Другой идентификатор: CTEP)
- NRG-GI004 (Другой идентификатор: NRG Oncology)
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .